Skip to content
Screener

West Pharmaceutical Services WST Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

AptarGroup logo
AptarGroupATR
$61.23M-8.0%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$30.85M-10.6%
Dow logo
DowDOW
$1.37B+9.7%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
9.3%0.0pp
Sonoco Products logo
Sonoco ProductsSON
$302.7M-4.8%
UFP Technologies logo
UFP TechnologiesUFPT
5.5%+0.3pp

Other financials

Income statement

See full
Revenue$872.3M+13.8%
Gross profit$329.2M+20.2%
Operating income$179.1M+16.5%
Net income$154.0M+16.8%
EPS (diluted)$2.15+18.1%

Balance sheet

See full
Cash & equivalents$435.8M-14.5%
Total debt$316.5M+2.7%
Total equity$3.0B+2.1%
Total assets$4.1B+3.1%

Cash flow

See full
Operating cash flow$124.0M-30.0%
CapEx$43.2M-42.6%
Free cash flow$80.8M-20.7%

Valuation

See full
Market cap$24.78B+43.4%
Enterprise value$24.66B+44.4%
P/E43.9×+8.4×
P/S7.5×+1.6×

Profitability

See full
Gross margin36.8%+1.5pp
Operating margin20.5%+0.8pp
Net margin17%+0.5pp
FCF margin13.1%+1.5pp

Returns & leverage

See full
Return on equity19.1%+1.4pp
Debt / equity0.1×0.0×
Current ratio2.8×0.0×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.

The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000105770-26-000099
Weighted average remaining lease term (in years):June 30,2026December 31,2025
Operating leases8.38.3
Finance leases4.14.4
Weighted average discount rate:
Operating leases4.72%4.67%
Finance leases4.09%4.15%

Item 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is West Pharmaceutical Services's operating lease ROU assets?
West Pharmaceutical Services (WST) reported operating lease ROU assets of 4.7% in Q2 2026.
How has West Pharmaceutical Services's operating lease ROU assets changed year-over-year?
West Pharmaceutical Services's operating lease ROU assets increased by 17.4% year-over-year, from 4% to 4.7%.
What is the long-term trend for West Pharmaceutical Services's operating lease ROU assets?
Over 5 years (2020 to 2025), West Pharmaceutical Services's operating lease ROU assets has grown at a -98.5% compound annual growth rate (CAGR), from 6,830,000,000% to 4.7%.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about West Pharmaceutical Services's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude